Literature DB >> 11359581

A phase-variable capsule is involved in virulence of Campylobacter jejuni 81-176.

D J Bacon1, C M Szymanski, D H Burr, R P Silver, R A Alm, P Guerry.   

Abstract

Campylobacter jejuni strain 81-176 (HS36, 23) synthesizes two distinct glycan structures, as visualized by immunoblotting of proteinase K-digested whole-cell preparations. A site-specific insertional mutant in the kpsM gene results in loss of expression of a high-molecular-weight (HMW) glycan (apparent Mr 26 kDa to > 85 kDa) and increased resolution of a second ladder-like glycan (apparent Mr 26-50 kDa). The kpsM mutant of 81-176 is no longer typeable in either HS23 or HS36 antisera, indicating that the HMW glycan structure is the serodeterminant of HS23 and HS36. Both the kpsM-dependent HMW glycan and the kpsM-independent ladder-like structure appear to be capsular in nature, as both are attached to phospholipid rather than lipid A. Additionally, the 81-176 kpsM gene can complement a deletion in Escherichia coli kpsM, allowing the expression of an alpha2,8 polysialic acid capsule in E. coli. Loss of the HMW glycan in 81-176 kpsM also increases the surface hydrophobicity and serum sensitivity of the bacterium. The kpsM mutant is also significantly reduced in invasion of INT407 cells and reduced in virulence in a ferret diarrhoeal disease model. The expression of the kpsM-dependent capsule undergoes phase variation at a high frequency.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11359581     DOI: 10.1046/j.1365-2958.2001.02431.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  136 in total

Review 1.  Phase and antigenic variation in bacteria.

Authors:  Marjan W van der Woude; Andreas J Bäumler
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

2.  A deep-rough mutant of Campylobacter jejuni 81-176 is noninvasive for intestinal epithelial cells.

Authors:  Margaret I Kanipes; Lindsay C Holder; Adrian T Corcoran; Anthony P Moran; Patricia Guerry
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

3.  Capsule shields the function of short bacterial adhesins.

Authors:  Mark A Schembri; Dorte Dalsgaard; Per Klemm
Journal:  J Bacteriol       Date:  2004-03       Impact factor: 3.490

4.  Campylobacter jejuni translocation across intestinal epithelial cells is facilitated by ganglioside-like lipooligosaccharide structures.

Authors:  Rogier Louwen; Edward E S Nieuwenhuis; Leonie van Marrewijk; Deborah Horst-Kreft; Lilian de Ruiter; Astrid P Heikema; Willem J B van Wamel; Jaap A Wagenaar; Hubert P Endtz; Janneke Samsom; Peter van Baarlen; Anna Akhmanova; Alex van Belkum
Journal:  Infect Immun       Date:  2012-07-09       Impact factor: 3.441

Review 5.  Insights into Campylobacter jejuni colonization of the mammalian intestinal tract using a novel mouse model of infection.

Authors:  Martin Stahl; Bruce A Vallance
Journal:  Gut Microbes       Date:  2015-04-01

6.  Structural and functional divergence of MutS2 from bacterial MutS1 and eukaryotic MSH4-MSH5 homologs.

Authors:  Josephine Kang; Shuyan Huang; Martin J Blaser
Journal:  J Bacteriol       Date:  2005-05       Impact factor: 3.490

7.  A sigma28-regulated nonflagella gene contributes to virulence of Campylobacter jejuni 81-176.

Authors:  Scarlett Goon; Cheryl P Ewing; Maria Lorenzo; Dawn Pattarini; Gary Majam; Patricia Guerry
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

8.  Campylobacter jejuni biofilms up-regulated in the absence of the stringent response utilize a calcofluor white-reactive polysaccharide.

Authors:  Meghan K McLennan; Danielle D Ringoir; Emilisa Frirdich; Sarah L Svensson; Derek H Wells; Harold Jarrell; Christine M Szymanski; Erin C Gaynor
Journal:  J Bacteriol       Date:  2007-11-09       Impact factor: 3.490

9.  The polysaccharide capsule of Campylobacter jejuni modulates the host immune response.

Authors:  Alexander C Maue; Krystle L Mohawk; David K Giles; Frédéric Poly; Cheryl P Ewing; Yuening Jiao; Ginyoung Lee; Zuchao Ma; Mario A Monteiro; Christina L Hill; Jason S Ferderber; Chad K Porter; M Stephen Trent; Patricia Guerry
Journal:  Infect Immun       Date:  2012-12-17       Impact factor: 3.441

10.  Roles of lipooligosaccharide and capsular polysaccharide in antimicrobial resistance and natural transformation of Campylobacter jejuni.

Authors:  Byeonghwa Jeon; Wayne Muraoka; Alexandra Scupham; Qijing Zhang
Journal:  J Antimicrob Chemother       Date:  2009-01-15       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.